In this webcast, Dr. Banerji discusses the diagnosis and approach to CLL management, the indications to treat and the decision making based on patient characteristics and molecular testing that leads to treatment decisions for approved and funded treatments.
Dr Versha Banerji MD FRCPC obtained her undergraduate degree, clinical training in medicine and hematology from The University of Manitoba. She completed additional training in translational research at the Dana-Farber Cancer Centre and the Broad institute of Harvard and MIT. She is the co-Lead of The CLL Clinic at CancerCare Manitoba/University of Manitoba. She is the Principal investigator on Clinical trials and has an interest in following clinical cohorts to understand the real world experience with novel treatments for CLL.
This webcast was made possible thanks to the support of: